Global Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
September 2018
147
About the Report
About the Report
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Scope of the Report:
This report focuses on the Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
The worldwide market for Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Market Segment by Applications, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
There are 15 Chapters to deeply display the global Cancer Treatment Drugs market.
Chapter 1, to describe Cancer Treatment Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cancer Treatment Drugs, with sales, revenue, and price of Cancer Treatment Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Treatment Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Products
Companies
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Table of Contents
Table of Contents
Table of Contents
1 Market Overview
1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy (Biologic Therapy)
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Cancer Treatment Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Cancer Treatment Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Cancer Treatment Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Cancer Treatment Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Cancer Treatment Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Cancer Treatment Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Cancer Treatment Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda
2.8.1 Business Overview
2.8.2 Cancer Treatment Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Cancer Treatment Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Cancer Treatment Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Astellas
2.11.1 Business Overview
2.11.2 Cancer Treatment Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck & Co.
2.12.1 Business Overview
2.12.2 Cancer Treatment Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sanofi
2.13.1 Business Overview
2.13.2 Cancer Treatment Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Bayer
2.14.1 Business Overview
2.14.2 Cancer Treatment Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Biogen Idec
2.15.1 Business Overview
2.15.2 Cancer Treatment Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Eisai
2.16.1 Business Overview
2.16.2 Cancer Treatment Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Teva
2.17.1 Business Overview
2.17.2 Cancer Treatment Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Otsuka
2.18.1 Business Overview
2.18.2 Cancer Treatment Drugs Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Merck KGaA
2.19.1 Business Overview
2.19.2 Cancer Treatment Drugs Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Ipsen
2.20.1 Business Overview
2.20.2 Cancer Treatment Drugs Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 AbbVie
2.21.1 Business Overview
2.2.2 Cancer Treatment Drugs Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Gilead Sciences
2.22.1 Business Overview
2.22.2 Cancer Treatment Drugs Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Treatment Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Treatment Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Treatment Drugs Market Analysis by Regions
4.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Treatment Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.5 South America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5 North America Cancer Treatment Drugs by Countries
5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6 Europe Cancer Treatment Drugs by Countries
6.1 Europe Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.3 UK Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.4 France Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Treatment Drugs by Countries
7.1 Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.5 India Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8 South America Cancer Treatment Drugs by Countries
8.1 South America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Treatment Drugs by Countries
9.1 Middle East and Africa Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
10 Global Cancer Treatment Drugs Market Segment by Type
10.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
10.2 Chemotherapy Sales Growth and Price
10.2.1 Global Chemotherapy Sales Growth (2013-2018)
10.2.2 Global Chemotherapy Price (2013-2018)
10.3 Targeted Therapy Sales Growth and Price
10.3.1 Global Targeted Therapy Sales Growth (2013-2018)
10.3.2 Global Targeted Therapy Price (2013-2018)
10.4 Immunotherapy Sales Growth and Price
10.4.1 Global Immunotherapy Sales Growth (2013-2018)
10.4.2 Global Immunotherapy Price (2013-2018)
10.5 Hormonal Therapy (Biologic Therapy) Sales Growth and Price
10.5.1 Global Hormonal Therapy (Biologic Therapy) Sales Growth (2013-2018)
10.5.2 Global Hormonal Therapy (Biologic Therapy) Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Cancer Treatment Drugs Market Segment by Application
11.1 Global Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
11.2 Blood Cancer Sales Growth (2013-2018)
11.3 Breast Cancer Sales Growth (2013-2018)
11.4 Gastrointestinal Cancer Sales Growth (2013-2018)
11.5 Prostate Cancer Sales Growth (2013-2018)
11.6 Respiratory/Lung Cancer Sales Growth (2013-2018)
11.7 Other Cancers Sales Growth (2013-2018)
12 Cancer Treatment Drugs Market Forecast (2018-2023)
12.1 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Treatment Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.2 Europe Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.4 South America Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Treatment Drugs Market Forecast (2018-2023)
12.3 Cancer Treatment Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
12.4 Cancer Treatment Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Table
List of Tables and Figures
Figure Cancer Treatment Drugs Picture
Table Product Specifications of Cancer Treatment Drugs
Figure Global Sales Market Share of Cancer Treatment Drugs by Types in 2017
Table Cancer Treatment Drugs Types for Major Manufacturers
Figure Chemotherapy Picture
Figure Targeted Therapy Picture
Figure Immunotherapy Picture
Figure Hormonal Therapy (Biologic Therapy) Picture
Figure Others Picture
Figure Cancer Treatment Drugs Sales Market Share by Applications in 2017
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Cancers Picture
Figure United States Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Treatment Drugs Type and Applications
Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Treatment Drugs Type and Applications
Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cancer Treatment Drugs Type and Applications
Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Treatment Drugs Type and Applications
Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Treatment Drugs Type and Applications
Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cancer Treatment Drugs Type and Applications
Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Treatment Drugs Type and Applications
Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Treatment Drugs Type and Applications
Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Cancer Treatment Drugs Type and Applications
Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Cancer Treatment Drugs Type and Applications
Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Treatment Drugs Type and Applications
Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cancer Treatment Drugs Type and Applications
Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Cancer Treatment Drugs Type and Applications
Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Cancer Treatment Drugs Type and Applications
Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Cancer Treatment Drugs Type and Applications
Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Cancer Treatment Drugs Type and Applications
Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGaA Basic Information, Manufacturing Base and Competitors
Table Merck KGaA Cancer Treatment Drugs Type and Applications
Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Cancer Treatment Drugs Type and Applications
Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Cancer Treatment Drugs Type and Applications
Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Cancer Treatment Drugs Type and Applications
Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Global Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Global Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Global Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Global Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Global Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Global Cancer Treatment Drugs Sales by Regions (2013-2018)
Table Global Cancer Treatment Drugs Sales Market Share by Regions (2013-2018)
Table Global Cancer Treatment Drugs Revenue by Regions (2013-2018)
Figure Global Cancer Treatment Drugs Revenue Market Share by Regions in 2013
Figure Global Cancer Treatment Drugs Revenue Market Share by Regions in 2017
Figure North America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Europe Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure North America Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table North America Cancer Treatment Drugs Sales by Countries (2013-2018)
Table North America Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure North America Cancer Treatment Drugs Sales Market Share by Countries in 2013
Figure North America Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table North America Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table North America Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Treatment Drugs Revenue Market Share by Countries in 2013
Figure North America Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure United States Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Canada Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Europe Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Europe Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Europe Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Table Europe Cancer Treatment Drugs Revenue by Countries (2013-2018)
Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Germany Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure UK Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure France Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Russia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Italy Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Cancer Treatment Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Countries 2017
Figure China Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Japan Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Korea Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure India Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South America Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table South America Cancer Treatment Drugs Sales by Countries (2013-2018)
Table South America Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure South America Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table South America Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table South America Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Brazil Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure UAE Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Table Global Cancer Treatment Drugs Sales by Type (2013-2018)
Table Global Cancer Treatment Drugs Sales Share by Type (2013-2018)
Table Global Cancer Treatment Drugs Revenue by Type (2013-2018)
Table Global Cancer Treatment Drugs Revenue Share by Type (2013-2018)
Figure Global Chemotherapy Sales Growth (2013-2018)
Figure Global Chemotherapy Price (2013-2018)
Figure Global Targeted Therapy Sales Growth (2013-2018)
Figure Global Targeted Therapy Price (2013-2018)
Figure Global Immunotherapy Sales Growth (2013-2018)
Figure Global Immunotherapy Price (2013-2018)
Figure Global Hormonal Therapy (Biologic Therapy) Sales Growth (2013-2018)
Figure Global Hormonal Therapy (Biologic Therapy) Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Cancer Treatment Drugs Sales by Application (2013-2018)
Table Global Cancer Treatment Drugs Sales Share by Application (2013-2018)
Figure Global Breast Cancer Sales Growth (2013-2018)
Figure Global Gastrointestinal Cancer Sales Growth (2013-2018)
Figure Global Prostate Cancer Sales Growth (2013-2018)
Figure Global Respiratory/Lung Cancer Sales Growth (2013-2018)
Figure Global Other Cancers Sales Growth (2013-2018)
Figure Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Cancer Treatment Drugs Sales Forecast by Regions (2018-2023)
Table Global Cancer Treatment Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Europe Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Figure South America Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Table Global Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
Table Global Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
Table Global Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
Table Global Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.